Facebook
Twitter
LinkedIn
ForwardTitle
Category
Credits
Event date
Cost
- Research to Practice
- 1.00 Participation
$0.00
Dr. Siddharth Sheth from the UNC Lineberger Head and Neck Oncology group will describe relevant updates in systemic therapy for head and neck cancers for health care providers throughout the state of North Carolina. Additional topical management considerations or recommendations for this patient population may also be presented.
- Research to Practice
- 1.00 Participation
$0.00
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.
- Advanced Practice Provider
- 1.00 Participation
$0.00
Webinar DescriptionBrian Colwell Jensen, MD, will review the potential cardiotoxicity associated with radiation therapy, chemotherapy, and newer targeted cancer therapies.
- Southeastern American Indian Cancer Health Equity Partnership
- 1.00 Participation
$0.00
Webinar DescriptionHannah E. Woriax, MD, will review several case scenarios and patient archetypes that have had their treatment course changed drastically due to recent landmark research studies. Dr. Woriax will then go through a few scenarios relevant to my current patient population specifically. Based on these patient scenarios, she will then discuss potential research possibilities for the future.
- Patient Centered Care
- 1.00 Participation
$0.00
Chemotherapy-induced neuropathy is a major clinical problem that can lead to persistent issues for cancer survivors and can even limit the use of planned chemotherapy treatment during the course of care. Cryotherapy is already an established treatment for other chemotherapy induced conditions such as alopecia and mouth mucositis. This course will explore the evidence for using this low-cost intervention to reduce the incidence/severity of chemotherapy-induced neuropathy.
- Patient Centered Care
- 1.00 Participation
$0.00
Genetic sequencing technologies are increasingly applied in the oncology setting for a variety of purposes. Genetic testing of tumor specimens can help clarify a diagnosis and inform targeted therapies. Kate Foreman, MS, CGC helps us navigate this field.
- Advanced Practice Provider
- 1.00 Participation
$0.00
Join Transfusion Medicine and Blood Bank Fellow, Mariama Evans, MD, for a review of transfusion reactions and their laboratory workup. Specific topics to include the most common transfusion reactions seen in cancer patients and the laboratory techniques utilized, such as Direct Antiglobulin Test (DAT) and elutions.
- Research to Practice
- 1.00 Participation
$0.00
Oral chemotherapy is becoming increasingly common in treatment of various malignancies. Although oral oncolytics are extremely beneficial for patients, they also present unique challenges for patients and providers alike. Implementing oral chemotherapy often requires a multidisciplinary approach. This lecture discusses several considerations for oral chemotherapy such as prescribing, patient education, adherence, medication access, cost and insurance authorization, monitoring, supportive care, and more. We will walk through a patient case to highlight practical suggestions for successful implementation of oral chemotherapy for patients.
- Patient Centered Care
- 1.00 Participation
$0.00
In this webinar, Angela Smith, MD, MS, FACS discusses the definition and use of electronic patient-reported outcomes (ePROs) and mobile health technology in optimizing postoperative cancer care.
Psycho-Social Complications of Receiving a Cancer Diagnosis and Treatment During the Pandemic - SPOC
- Patient Centered Care
- 1.00 Participation
$0.00
This presentation focuses on the unique psychosocial complications related to being diagnosed with - and treated for - cancer during the COVID pandemic.